Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.13.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
HK.13.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HV.1.9NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
HV.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.16NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBB.2.3.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.59NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.2.59NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-15533.3Singapore
BR.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BR.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.7NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BQ.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.5.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
CM.5.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBDNYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBDNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EB.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
EB.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.637.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.637.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.79NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.2.79NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BG.3NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BG.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.10NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.2.3.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KN.1.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
KN.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.1.4.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BE.1.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
CH.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.53NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.5.2.53NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BL.6NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BL.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.9NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
CM.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.4.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBB.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JB.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JB.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.4NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
A.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDK.4NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XDK.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.58NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-1896.83Singapore
BA.2.58NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.1.6NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used